DE3853910D1 - Molekulare köder und deren verwendung. - Google Patents

Molekulare köder und deren verwendung.

Info

Publication number
DE3853910D1
DE3853910D1 DE3853910T DE3853910T DE3853910D1 DE 3853910 D1 DE3853910 D1 DE 3853910D1 DE 3853910 T DE3853910 T DE 3853910T DE 3853910 T DE3853910 T DE 3853910T DE 3853910 D1 DE3853910 D1 DE 3853910D1
Authority
DE
Germany
Prior art keywords
receptor
pct
decoyant
retains
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853910T
Other languages
English (en)
Other versions
DE3853910T2 (de
Inventor
Jonathan M Gershoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3853910D1 publication Critical patent/DE3853910D1/de
Publication of DE3853910T2 publication Critical patent/DE3853910T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
  • Polyamides (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Paper (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3853910T 1987-08-30 1988-08-30 Molekulare köder und deren verwendung. Expired - Fee Related DE3853910T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
PCT/US1988/002991 WO1989001779A1 (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof

Publications (2)

Publication Number Publication Date
DE3853910D1 true DE3853910D1 (de) 1995-07-06
DE3853910T2 DE3853910T2 (de) 1995-10-12

Family

ID=11058121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853910T Expired - Fee Related DE3853910T2 (de) 1987-08-30 1988-08-30 Molekulare köder und deren verwendung.

Country Status (12)

Country Link
US (1) US5770572A (de)
EP (1) EP0329778B1 (de)
JP (1) JP2791074B2 (de)
AT (1) ATE123224T1 (de)
AU (1) AU2383988A (de)
CA (1) CA1336489C (de)
DE (1) DE3853910T2 (de)
DK (1) DK175596B1 (de)
FI (1) FI100169B (de)
IL (1) IL83687A (de)
NO (1) NO891787L (de)
WO (1) WO1989001779A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001940A1 (en) * 1987-09-04 1989-03-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
US5132402A (en) * 1987-11-25 1992-07-21 Agency Of Industrial Science And Technology Adsorbent, method for production thereof, and method for use thereof
EP0318240A3 (de) * 1987-11-25 1990-08-16 AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY Peptidadsorbens, Methode zu dessen Herstellung und dessen Verwendung
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
ITRM20010563A1 (it) * 2001-09-14 2003-03-14 Univ Siena Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente.
US8535672B2 (en) 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
RU2005102604A (ru) * 2002-07-03 2005-09-10 Перикор Сайенс, Инк. (Us) Композиция гиалуроновой кислоты и способы применения
JP4495776B1 (ja) * 2009-07-30 2010-07-07 日本製薬株式会社 融合蛋白質
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
WO2015153647A1 (en) * 2014-03-31 2015-10-08 Mice With Horns, Llc Method of preventing or reducing virus transmission in animals
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
AU616639B2 (en) * 1986-08-21 1991-11-07 Trustees Of Columbia University In The City Of New York, The Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
US5126433A (en) * 1986-08-21 1992-06-30 The Trustees Of Columbia University In The City Of New York Soluble forms of the t cell surface protein cd4

Also Published As

Publication number Publication date
IL83687A (en) 1995-03-30
NO891787L (no) 1989-06-06
NO891787D0 (no) 1989-04-28
DK211989A (da) 1989-06-28
ATE123224T1 (de) 1995-06-15
WO1989001779A1 (en) 1989-03-09
DK175596B1 (da) 2004-12-13
US5770572A (en) 1998-06-23
JPH02502538A (ja) 1990-08-16
JP2791074B2 (ja) 1998-08-27
DE3853910T2 (de) 1995-10-12
DK211989D0 (da) 1989-05-01
EP0329778B1 (de) 1995-05-31
EP0329778A4 (en) 1990-12-27
FI892005A0 (fi) 1989-04-27
IL83687A0 (de) 1988-01-31
FI892005A (fi) 1989-04-27
EP0329778A1 (de) 1989-08-30
CA1336489C (en) 1995-08-01
AU2383988A (en) 1989-03-31
FI100169B (fi) 1997-10-15

Similar Documents

Publication Publication Date Title
DE3853910D1 (de) Molekulare köder und deren verwendung.
BR9710375A (pt) Processo e composi-Æo farmac-utica ou veterin ria para a inibi-Æo profil tica ou terap-utica da angiog-nese em um ser humano ou animal nÆo humano uso de um pol¡mero ou dendr¡mero tendo uma pluralidade de grupos terminais
BR0015506A (pt) Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
GT199700093A (es) Derivados 6,6-heterobiciclicos sustituidos.
PT99445A (pt) Processo para preparacao de derivados do 1,4,7,10-tetraazaciclododecano mono-n--substituidos e de composicoes farmaceuticas que os contem
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
PT83572B (pt) Processo para a preparacao de compostos heterociclicos de quinoxalina e de composicoes farmaceuticas que os contem
DE69029654D1 (de) Verwendung von lipoxin a 4? und dessen derivaten als antagonisten für trägreagierende anaphylaxmittel
ES2117299T3 (es) Aparato para la inyeccion embrionaria temprana "in ovo".
EE200000039A (et) MHC II klassi ligandi kasutamine, farmatseutiline kompositsioon, transfekteeritud kasvajarakud, transfekteeritud rakkude ja kasvajarakkude valmistamismeetod ning nende kasutamine
BR9507073A (pt) Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto
DE69724804D1 (de) Pestizide zusammensetzung und verfahren zur anwendung
DE3877547D1 (de) Basisches protein phospholipase a2 aus dem gift der schlangen aus der familie der elapiden, deren aminosaeuresequenz, derivate und fragmente dieses proteins, verfahren um es zu erhalten, therapeutische kompositionen und diagnosemittel, alle dieses protein enthaltend und/oder dessen derivate und/oder dessen fragmente.
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
DE3872872D1 (de) 5-ht3-rezeptor-antagonisten zur behandlung von husten und bronchokonstriktion.
TR199701576T1 (xx) N-aril-1,2,4,-triazolin-5-onlar.
DE69634510D1 (de) Streptococcus toxinmutanten und verfahren zu deren anwendung
ATE90181T1 (de) Verwendung von pankreatin enthaltendem futter oder praemix fuer rennpferde und rennkamele.
MX14957A (es) Nuevos derivados de tetrazol y procedimiento para su preparacion.
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee